| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stents | 77 | 2023 | 869 | 9.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 46 | 2024 | 444 | 8.340 |
Why?
|
| Transcatheter Aortic Valve Replacement | 19 | 2024 | 203 | 8.300 |
Why?
|
| Blood Vessel Prosthesis Implantation | 52 | 2024 | 786 | 8.120 |
Why?
|
| Endovascular Procedures | 36 | 2024 | 767 | 7.870 |
Why?
|
| Blood Vessel Prosthesis | 38 | 2020 | 538 | 7.070 |
Why?
|
| Aortic Valve Stenosis | 16 | 2022 | 343 | 6.400 |
Why?
|
| Heart Valve Prosthesis Implantation | 12 | 2022 | 449 | 4.960 |
Why?
|
| Heart Valve Prosthesis | 17 | 2022 | 305 | 4.890 |
Why?
|
| Treatment Outcome | 109 | 2024 | 12957 | 4.370 |
Why?
|
| Percutaneous Coronary Intervention | 8 | 2023 | 280 | 4.180 |
Why?
|
| Angioplasty, Balloon | 19 | 2017 | 158 | 3.310 |
Why?
|
| Aortic Valve | 17 | 2022 | 452 | 3.200 |
Why?
|
| Vascular Closure Devices | 8 | 2024 | 15 | 3.170 |
Why?
|
| Prosthesis Design | 33 | 2025 | 706 | 2.510 |
Why?
|
| Femoral Artery | 21 | 2021 | 190 | 2.450 |
Why?
|
| Pulmonary Valve | 4 | 2020 | 94 | 2.300 |
Why?
|
| Hemostatic Techniques | 8 | 2024 | 33 | 2.260 |
Why?
|
| Coronary Artery Disease | 7 | 2023 | 859 | 2.230 |
Why?
|
| Carotid Stenosis | 11 | 2018 | 134 | 2.200 |
Why?
|
| Aortic Aneurysm, Thoracic | 10 | 2024 | 677 | 1.980 |
Why?
|
| Aorta, Abdominal | 8 | 2018 | 125 | 1.890 |
Why?
|
| Catheterization, Peripheral | 7 | 2024 | 126 | 1.890 |
Why?
|
| Angioplasty | 8 | 2018 | 80 | 1.850 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2022 | 174 | 1.810 |
Why?
|
| Aortic Aneurysm | 4 | 2020 | 233 | 1.760 |
Why?
|
| Humans | 183 | 2025 | 133290 | 1.730 |
Why?
|
| Patient Discharge | 4 | 2019 | 515 | 1.700 |
Why?
|
| Cardiac Catheterization | 15 | 2022 | 645 | 1.680 |
Why?
|
| Arterial Occlusive Diseases | 11 | 2016 | 127 | 1.610 |
Why?
|
| Aneurysm | 8 | 2018 | 89 | 1.550 |
Why?
|
| Aortography | 20 | 2019 | 192 | 1.470 |
Why?
|
| Mitral Valve | 10 | 2023 | 266 | 1.460 |
Why?
|
| Peripheral Arterial Disease | 5 | 2020 | 310 | 1.380 |
Why?
|
| Foramen Ovale, Patent | 2 | 2021 | 19 | 1.350 |
Why?
|
| Aortic Diseases | 3 | 2020 | 203 | 1.290 |
Why?
|
| Aneurysm, False | 4 | 2018 | 94 | 1.290 |
Why?
|
| Aortic Coarctation | 4 | 2017 | 110 | 1.290 |
Why?
|
| Suture Techniques | 7 | 2024 | 201 | 1.230 |
Why?
|
| Time Factors | 31 | 2024 | 6562 | 1.220 |
Why?
|
| Bioprosthesis | 3 | 2021 | 117 | 1.200 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 152 | 1.190 |
Why?
|
| Conscious Sedation | 3 | 2021 | 61 | 1.170 |
Why?
|
| Popliteal Artery | 6 | 2016 | 51 | 1.160 |
Why?
|
| Artificial Intelligence | 2 | 2022 | 286 | 1.160 |
Why?
|
| Endoleak | 4 | 2019 | 47 | 1.110 |
Why?
|
| Thrombectomy | 6 | 2020 | 104 | 1.110 |
Why?
|
| Stroke | 5 | 2021 | 1067 | 1.100 |
Why?
|
| Length of Stay | 7 | 2021 | 1373 | 1.100 |
Why?
|
| Aged | 73 | 2024 | 21619 | 1.070 |
Why?
|
| Aorta, Thoracic | 4 | 2020 | 540 | 1.070 |
Why?
|
| Punctures | 7 | 2024 | 59 | 1.030 |
Why?
|
| Peripheral Vascular Diseases | 5 | 2011 | 86 | 1.020 |
Why?
|
| Anesthesia, Local | 2 | 2019 | 44 | 1.000 |
Why?
|
| Hemorrhage | 5 | 2024 | 503 | 0.990 |
Why?
|
| Aged, 80 and over | 33 | 2024 | 7184 | 0.980 |
Why?
|
| Vascular Surgical Procedures | 9 | 2013 | 560 | 0.970 |
Why?
|
| Heart Septum | 5 | 2021 | 55 | 0.940 |
Why?
|
| Thrombosis | 6 | 2018 | 534 | 0.910 |
Why?
|
| Iliac Artery | 7 | 2003 | 81 | 0.860 |
Why?
|
| Academies and Institutes | 2 | 2023 | 89 | 0.850 |
Why?
|
| Endarterectomy, Carotid | 5 | 2018 | 94 | 0.840 |
Why?
|
| Registries | 8 | 2020 | 1551 | 0.820 |
Why?
|
| Embolization, Therapeutic | 4 | 2017 | 223 | 0.820 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2016 | 2214 | 0.810 |
Why?
|
| Vascular Fistula | 2 | 2018 | 31 | 0.790 |
Why?
|
| Absorbable Implants | 2 | 2023 | 27 | 0.770 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2022 | 64 | 0.770 |
Why?
|
| Triiodobenzoic Acids | 1 | 2022 | 32 | 0.760 |
Why?
|
| Machine Learning | 2 | 2022 | 325 | 0.730 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 557 | 0.730 |
Why?
|
| Atherectomy, Coronary | 2 | 2021 | 10 | 0.720 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2021 | 17 | 0.710 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2021 | 1151 | 0.690 |
Why?
|
| Male | 84 | 2024 | 65619 | 0.690 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2017 | 182 | 0.690 |
Why?
|
| Prostheses and Implants | 2 | 2020 | 158 | 0.690 |
Why?
|
| Risk Factors | 21 | 2024 | 11006 | 0.680 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 180 | 0.680 |
Why?
|
| Coronary Occlusion | 1 | 2020 | 29 | 0.680 |
Why?
|
| Prospective Studies | 17 | 2024 | 6629 | 0.670 |
Why?
|
| Hemostatics | 1 | 2020 | 60 | 0.660 |
Why?
|
| Vascular Calcification | 1 | 2021 | 67 | 0.660 |
Why?
|
| Pulmonary Artery | 3 | 2020 | 451 | 0.660 |
Why?
|
| Renal Artery | 2 | 2016 | 70 | 0.660 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2019 | 197 | 0.660 |
Why?
|
| Hemostasis | 1 | 2020 | 70 | 0.650 |
Why?
|
| Contrast Media | 2 | 2022 | 515 | 0.650 |
Why?
|
| Cryotherapy | 2 | 2011 | 22 | 0.640 |
Why?
|
| Stenosis, Pulmonary Artery | 1 | 2019 | 5 | 0.630 |
Why?
|
| Carotid Artery, Common | 5 | 2007 | 69 | 0.620 |
Why?
|
| Transplant Recipients | 1 | 2021 | 225 | 0.620 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 58 | 0.620 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2020 | 94 | 0.620 |
Why?
|
| Middle Aged | 64 | 2024 | 29237 | 0.610 |
Why?
|
| Postoperative Complications | 14 | 2018 | 3204 | 0.610 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2020 | 93 | 0.610 |
Why?
|
| Coronary Restenosis | 2 | 2017 | 25 | 0.610 |
Why?
|
| Female | 79 | 2024 | 71345 | 0.600 |
Why?
|
| Septal Occluder Device | 1 | 2019 | 45 | 0.590 |
Why?
|
| Heart-Assist Devices | 3 | 2025 | 1068 | 0.590 |
Why?
|
| Equipment Design | 11 | 2024 | 611 | 0.590 |
Why?
|
| Heart | 3 | 2023 | 755 | 0.590 |
Why?
|
| Leadership | 1 | 2021 | 243 | 0.590 |
Why?
|
| Aortic Rupture | 2 | 2018 | 120 | 0.590 |
Why?
|
| Hospital Costs | 1 | 2019 | 186 | 0.580 |
Why?
|
| Vascular Patency | 8 | 2020 | 195 | 0.580 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2019 | 119 | 0.570 |
Why?
|
| Follow-Up Studies | 30 | 2019 | 5481 | 0.570 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 204 | 0.570 |
Why?
|
| Retrospective Studies | 30 | 2021 | 17380 | 0.570 |
Why?
|
| Vena Cava, Inferior | 1 | 2018 | 104 | 0.570 |
Why?
|
| Prosthesis Failure | 6 | 2012 | 168 | 0.560 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 114 | 0.560 |
Why?
|
| Radiography | 14 | 2016 | 826 | 0.550 |
Why?
|
| Lasers | 1 | 2017 | 117 | 0.540 |
Why?
|
| Atrial Appendage | 1 | 2017 | 51 | 0.540 |
Why?
|
| Drug-Eluting Stents | 1 | 2017 | 69 | 0.530 |
Why?
|
| Aspirin | 1 | 2018 | 232 | 0.520 |
Why?
|
| Norwood Procedures | 1 | 2017 | 101 | 0.520 |
Why?
|
| Lung Diseases | 1 | 2020 | 398 | 0.510 |
Why?
|
| Women's Health | 1 | 2017 | 150 | 0.510 |
Why?
|
| Internship and Residency | 2 | 2021 | 1249 | 0.500 |
Why?
|
| Equipment Failure | 3 | 2008 | 131 | 0.490 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2017 | 109 | 0.490 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2016 | 42 | 0.490 |
Why?
|
| Cardiology | 1 | 2021 | 519 | 0.470 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 83 | 0.470 |
Why?
|
| Algorithms | 2 | 2022 | 1726 | 0.470 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 148 | 0.470 |
Why?
|
| Lower Extremity | 3 | 2016 | 188 | 0.460 |
Why?
|
| Vascular Malformations | 1 | 2016 | 104 | 0.460 |
Why?
|
| Feasibility Studies | 6 | 2018 | 817 | 0.460 |
Why?
|
| Vascular Access Devices | 2 | 2015 | 36 | 0.460 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 775 | 0.450 |
Why?
|
| Renal Artery Obstruction | 2 | 2008 | 41 | 0.440 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 528 | 0.440 |
Why?
|
| Texas | 12 | 2011 | 3677 | 0.430 |
Why?
|
| Hospitals, High-Volume | 1 | 2014 | 38 | 0.430 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2020 | 280 | 0.420 |
Why?
|
| Myocardial Infarction | 3 | 2020 | 1084 | 0.410 |
Why?
|
| Risk Assessment | 10 | 2021 | 3665 | 0.410 |
Why?
|
| Renal Dialysis | 1 | 2020 | 875 | 0.410 |
Why?
|
| Angiography | 10 | 2016 | 214 | 0.400 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 204 | 0.390 |
Why?
|
| Surgical Wound Infection | 2 | 2006 | 275 | 0.380 |
Why?
|
| Inpatients | 1 | 2016 | 532 | 0.380 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 472 | 0.380 |
Why?
|
| United States | 8 | 2021 | 11633 | 0.370 |
Why?
|
| Research Design | 2 | 2015 | 757 | 0.370 |
Why?
|
| Tricuspid Valve | 2 | 2022 | 64 | 0.370 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2011 | 19 | 0.350 |
Why?
|
| Intracranial Embolism | 1 | 2010 | 30 | 0.350 |
Why?
|
| Reoperation | 7 | 2012 | 864 | 0.350 |
Why?
|
| Metals | 2 | 2020 | 64 | 0.340 |
Why?
|
| Forecasting | 2 | 2022 | 375 | 0.340 |
Why?
|
| Catheters | 1 | 2010 | 84 | 0.340 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 679 | 0.330 |
Why?
|
| Iliac Vein | 1 | 2010 | 30 | 0.330 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 72 | 0.320 |
Why?
|
| Sutures | 2 | 2020 | 67 | 0.310 |
Why?
|
| Incidence | 5 | 2022 | 3381 | 0.300 |
Why?
|
| Embolism | 1 | 2009 | 47 | 0.300 |
Why?
|
| Recurrence | 9 | 2008 | 1464 | 0.300 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2006 | 39 | 0.290 |
Why?
|
| Hemodynamics | 7 | 2020 | 870 | 0.280 |
Why?
|
| Carotid Artery Diseases | 2 | 2006 | 148 | 0.280 |
Why?
|
| Operative Time | 2 | 2019 | 183 | 0.270 |
Why?
|
| Computed Tomography Angiography | 2 | 2019 | 208 | 0.270 |
Why?
|
| Heart Arrest | 1 | 2011 | 376 | 0.260 |
Why?
|
| Anesthesia, General | 2 | 2018 | 119 | 0.260 |
Why?
|
| Congresses as Topic | 2 | 2017 | 187 | 0.250 |
Why?
|
| Thrombolytic Therapy | 3 | 2011 | 209 | 0.250 |
Why?
|
| Carotid Artery Injuries | 1 | 2006 | 38 | 0.250 |
Why?
|
| Stroke Volume | 6 | 2019 | 538 | 0.250 |
Why?
|
| Cardiomyopathy, Hypertrophic | 7 | 1989 | 158 | 0.250 |
Why?
|
| Coronary Disease | 8 | 2001 | 718 | 0.250 |
Why?
|
| Celiac Artery | 1 | 2006 | 33 | 0.250 |
Why?
|
| Aorta | 3 | 2020 | 556 | 0.250 |
Why?
|
| Arteriovenous Fistula | 1 | 2006 | 55 | 0.240 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2017 | 257 | 0.240 |
Why?
|
| Program Evaluation | 2 | 2018 | 455 | 0.230 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 565 | 0.230 |
Why?
|
| Elective Surgical Procedures | 2 | 2016 | 167 | 0.230 |
Why?
|
| Hemolysis | 1 | 2025 | 113 | 0.230 |
Why?
|
| Polytetrafluoroethylene | 4 | 2010 | 76 | 0.220 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2004 | 9 | 0.220 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 204 | 0.220 |
Why?
|
| Catheters, Indwelling | 2 | 2002 | 141 | 0.210 |
Why?
|
| Coronary Angiography | 7 | 2020 | 469 | 0.210 |
Why?
|
| Intestinal Fistula | 1 | 2002 | 28 | 0.200 |
Why?
|
| North America | 2 | 2020 | 261 | 0.200 |
Why?
|
| Iohexol | 1 | 2022 | 23 | 0.190 |
Why?
|
| Credentialing | 1 | 2022 | 17 | 0.190 |
Why?
|
| Heart Ventricles | 6 | 2021 | 799 | 0.190 |
Why?
|
| Adult | 32 | 2019 | 31851 | 0.180 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 3058 | 0.180 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 573 | 0.180 |
Why?
|
| Survival Rate | 3 | 2018 | 2201 | 0.180 |
Why?
|
| Constriction, Pathologic | 3 | 2010 | 241 | 0.180 |
Why?
|
| Sirolimus | 1 | 2023 | 254 | 0.180 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 63 | 0.180 |
Why?
|
| Phlebography | 2 | 2011 | 44 | 0.170 |
Why?
|
| Patient Selection | 2 | 2017 | 731 | 0.170 |
Why?
|
| Latin America | 1 | 2020 | 99 | 0.170 |
Why?
|
| Radial Artery | 1 | 2020 | 29 | 0.170 |
Why?
|
| Dissent and Disputes | 1 | 2020 | 32 | 0.170 |
Why?
|
| Comorbidity | 5 | 2015 | 1602 | 0.170 |
Why?
|
| Carotid Arteries | 1 | 2001 | 151 | 0.170 |
Why?
|
| Prosthesis-Related Infections | 1 | 2002 | 185 | 0.170 |
Why?
|
| Myocardial Reperfusion | 1 | 2020 | 73 | 0.170 |
Why?
|
| Echocardiography | 7 | 2016 | 1113 | 0.170 |
Why?
|
| Arteriovenous Malformations | 1 | 2000 | 48 | 0.170 |
Why?
|
| Arm | 1 | 2000 | 81 | 0.170 |
Why?
|
| Hope | 1 | 2020 | 15 | 0.170 |
Why?
|
| Suction | 2 | 2010 | 58 | 0.160 |
Why?
|
| Skull | 1 | 2001 | 147 | 0.160 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1999 | 7 | 0.160 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 603 | 0.160 |
Why?
|
| Japan | 1 | 2020 | 156 | 0.160 |
Why?
|
| Retreatment | 1 | 2019 | 92 | 0.160 |
Why?
|
| Patient Readmission | 2 | 2020 | 404 | 0.160 |
Why?
|
| Cost Savings | 1 | 2019 | 75 | 0.160 |
Why?
|
| Solutions | 1 | 2019 | 67 | 0.160 |
Why?
|
| Off-Label Use | 1 | 2019 | 28 | 0.150 |
Why?
|
| Pilot Projects | 3 | 2010 | 1484 | 0.150 |
Why?
|
| Pennsylvania | 1 | 2018 | 60 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 188 | 0.150 |
Why?
|
| Coronary Vessels | 2 | 2022 | 556 | 0.150 |
Why?
|
| Ticlopidine | 1 | 2018 | 30 | 0.150 |
Why?
|
| Radiation Injuries | 1 | 2000 | 164 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Duplex | 4 | 2007 | 44 | 0.140 |
Why?
|
| Arteriosclerosis | 4 | 2005 | 149 | 0.140 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2017 | 18 | 0.140 |
Why?
|
| Polyvinyls | 1 | 2017 | 13 | 0.140 |
Why?
|
| Device Removal | 4 | 2002 | 221 | 0.140 |
Why?
|
| Dreams | 1 | 2017 | 23 | 0.140 |
Why?
|
| Cardiologists | 1 | 2017 | 23 | 0.140 |
Why?
|
| Everolimus | 1 | 2017 | 50 | 0.140 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2017 | 22 | 0.140 |
Why?
|
| Fibrosis | 1 | 2019 | 464 | 0.130 |
Why?
|
| Creatinine | 1 | 2019 | 423 | 0.130 |
Why?
|
| Adenosine | 1 | 2018 | 136 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2011 | 1133 | 0.130 |
Why?
|
| Paclitaxel | 1 | 2017 | 141 | 0.130 |
Why?
|
| Balloon Valvuloplasty | 1 | 2016 | 25 | 0.130 |
Why?
|
| Heterografts | 1 | 2017 | 194 | 0.130 |
Why?
|
| Time Management | 1 | 2016 | 12 | 0.130 |
Why?
|
| Ductus Arteriosus | 1 | 2017 | 62 | 0.130 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 58 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 252 | 0.130 |
Why?
|
| Suture Anchors | 1 | 2015 | 3 | 0.130 |
Why?
|
| Saphenous Vein | 2 | 2006 | 60 | 0.130 |
Why?
|
| Child | 6 | 2020 | 25678 | 0.120 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2015 | 32 | 0.120 |
Why?
|
| Paraplegia | 1 | 2016 | 91 | 0.120 |
Why?
|
| Pressure | 1 | 2016 | 138 | 0.120 |
Why?
|
| Transposition of Great Vessels | 1 | 2017 | 133 | 0.120 |
Why?
|
| Cineangiography | 1 | 2015 | 16 | 0.120 |
Why?
|
| Brachiocephalic Trunk | 2 | 2005 | 40 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 472 | 0.120 |
Why?
|
| Ischemia | 2 | 2015 | 382 | 0.120 |
Why?
|
| Contraindications | 1 | 2015 | 81 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 1314 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 559 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2018 | 340 | 0.120 |
Why?
|
| Kidney | 1 | 2022 | 1405 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 170 | 0.110 |
Why?
|
| Sex Factors | 1 | 2018 | 1374 | 0.110 |
Why?
|
| Coronary Artery Bypass | 5 | 2013 | 526 | 0.110 |
Why?
|
| Syndrome | 2 | 2010 | 1148 | 0.110 |
Why?
|
| Iatrogenic Disease | 2 | 2008 | 136 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2018 | 534 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 239 | 0.110 |
Why?
|
| Critical Care | 1 | 2019 | 680 | 0.110 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2015 | 55 | 0.110 |
Why?
|
| Heart Aneurysm | 2 | 1992 | 37 | 0.110 |
Why?
|
| Swine | 1 | 2017 | 1214 | 0.110 |
Why?
|
| Calcinosis | 1 | 2015 | 193 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 274 | 0.100 |
Why?
|
| Intermittent Claudication | 2 | 2003 | 60 | 0.100 |
Why?
|
| Polyethylene Terephthalates | 1 | 1992 | 46 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2015 | 402 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 624 | 0.100 |
Why?
|
| Pericardium | 1 | 1992 | 85 | 0.090 |
Why?
|
| Prevalence | 1 | 2018 | 2647 | 0.090 |
Why?
|
| Interinstitutional Relations | 1 | 2011 | 20 | 0.090 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 546 | 0.090 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 45 | 0.090 |
Why?
|
| Permeability | 1 | 2011 | 132 | 0.090 |
Why?
|
| Certification | 1 | 2011 | 72 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 674 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 99 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2008 | 992 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 1486 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 394 | 0.080 |
Why?
|
| Limb Salvage | 1 | 2011 | 137 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 229 | 0.080 |
Why?
|
| Brachiocephalic Veins | 2 | 2005 | 14 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2009 | 118 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3629 | 0.070 |
Why?
|
| Hypertension, Renovascular | 1 | 2008 | 29 | 0.070 |
Why?
|
| Costs and Cost Analysis | 3 | 2019 | 165 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2011 | 1337 | 0.070 |
Why?
|
| Pulmonary Edema | 1 | 2008 | 51 | 0.070 |
Why?
|
| Collateral Circulation | 2 | 2005 | 44 | 0.070 |
Why?
|
| Takayasu Arteritis | 2 | 1996 | 13 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 666 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2011 | 570 | 0.060 |
Why?
|
| Logistic Models | 1 | 2011 | 1903 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 168 | 0.060 |
Why?
|
| Polyesters | 2 | 2006 | 43 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 370 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2006 | 142 | 0.060 |
Why?
|
| Curriculum | 1 | 2011 | 775 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 2006 | 286 | 0.060 |
Why?
|
| Arteries | 1 | 2006 | 221 | 0.060 |
Why?
|
| Materials Testing | 1 | 2025 | 79 | 0.060 |
Why?
|
| Cattle | 1 | 2025 | 587 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2005 | 158 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2011 | 1057 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2025 | 323 | 0.050 |
Why?
|
| Infant | 1 | 2019 | 13107 | 0.050 |
Why?
|
| Eikenella corrodens | 1 | 2002 | 4 | 0.050 |
Why?
|
| Blood Circulation | 1 | 2002 | 21 | 0.050 |
Why?
|
| Fusobacterium Infections | 1 | 2002 | 14 | 0.050 |
Why?
|
| Equipment Safety | 1 | 2002 | 37 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2019 | 5174 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 476 | 0.050 |
Why?
|
| Brachial Artery | 2 | 1982 | 42 | 0.050 |
Why?
|
| Coronary Vessel Anomalies | 4 | 1980 | 288 | 0.050 |
Why?
|
| Wound Healing | 1 | 2006 | 496 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 398 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2002 | 64 | 0.050 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2001 | 15 | 0.040 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2001 | 8 | 0.040 |
Why?
|
| Time | 1 | 2001 | 99 | 0.040 |
Why?
|
| Animals | 2 | 2025 | 36265 | 0.040 |
Why?
|
| Subclavian Artery | 1 | 2001 | 73 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2002 | 220 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2002 | 595 | 0.040 |
Why?
|
| Streptococcal Infections | 1 | 2002 | 248 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2001 | 213 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2001 | 207 | 0.040 |
Why?
|
| Rupture | 1 | 1999 | 34 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2000 | 107 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2000 | 65 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2002 | 403 | 0.040 |
Why?
|
| Cineradiography | 1 | 1998 | 4 | 0.040 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 21 | 0.040 |
Why?
|
| Fistula | 1 | 1978 | 53 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2002 | 1408 | 0.030 |
Why?
|
| Thoracic Injuries | 1 | 1977 | 93 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2013 | 1596 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 1068 | 0.030 |
Why?
|
| Leg | 1 | 1997 | 156 | 0.030 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1977 | 134 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1977 | 219 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 88 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1243 | 0.030 |
Why?
|
| Echocardiography, Doppler | 2 | 1998 | 172 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 2294 | 0.030 |
Why?
|
| Counterpulsation | 1 | 1992 | 4 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1996 | 390 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 328 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 442 | 0.020 |
Why?
|
| Adolescent | 7 | 2013 | 20480 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 1992 | 120 | 0.020 |
Why?
|
| Exercise Test | 2 | 1983 | 266 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 3836 | 0.020 |
Why?
|
| Mitral Valve Stenosis | 2 | 1989 | 36 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 1996 | 1064 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 313 | 0.020 |
Why?
|
| Electrocardiography | 5 | 1987 | 1005 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1989 | 270 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1989 | 171 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 249 | 0.020 |
Why?
|
| Systole | 2 | 2002 | 207 | 0.020 |
Why?
|
| Endocarditis, Bacterial | 1 | 1988 | 137 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1987 | 136 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1989 | 251 | 0.020 |
Why?
|
| Angina Pectoris | 2 | 1985 | 61 | 0.020 |
Why?
|
| Life Tables | 1 | 2005 | 28 | 0.020 |
Why?
|
| Safety | 1 | 2006 | 223 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 1983 | 158 | 0.010 |
Why?
|
| Alloys | 1 | 2005 | 15 | 0.010 |
Why?
|
| Elasticity | 1 | 2005 | 94 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2006 | 314 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 3057 | 0.010 |
Why?
|
| Atropine | 1 | 2002 | 31 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 1475 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2002 | 24 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2002 | 39 | 0.010 |
Why?
|
| Bradycardia | 1 | 2002 | 63 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 64 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 316 | 0.010 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2002 | 42 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 262 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2002 | 224 | 0.010 |
Why?
|
| Hypotension | 1 | 2002 | 191 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1981 | 175 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9872 | 0.010 |
Why?
|
| Lutembacher Syndrome | 1 | 1978 | 1 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1999 | 197 | 0.010 |
Why?
|
| Warfarin | 1 | 1998 | 124 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 570 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 1996 | 34 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1977 | 153 | 0.010 |
Why?
|
| Heart Failure | 1 | 1989 | 2380 | 0.010 |
Why?
|
| Prognosis | 2 | 2002 | 5065 | 0.010 |
Why?
|
| Catheterization | 1 | 1996 | 236 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1989 | 14748 | 0.010 |
Why?
|
| Pronation | 1 | 1989 | 5 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1987 | 13 | 0.000 |
Why?
|
| Dilatation, Pathologic | 1 | 1987 | 96 | 0.000 |
Why?
|
| Heart Atria | 1 | 1989 | 335 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1985 | 69 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1985 | 411 | 0.000 |
Why?
|
| Transillumination | 1 | 1981 | 3 | 0.000 |
Why?
|
| Dilatation | 1 | 1981 | 70 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1985 | 524 | 0.000 |
Why?
|
| Risk | 1 | 1981 | 833 | 0.000 |
Why?
|
| Sinus of Valsalva | 1 | 1979 | 35 | 0.000 |
Why?
|
| Hospitalization | 1 | 1985 | 1871 | 0.000 |
Why?
|